Disease | hepatitis |
Phenotype | |liver disease |
Sentences | 177 |
PubMedID- 22448309 | Reported four adults being assessed for liver transplantation because of chronic liver diseases (three with cryptogenic hepatitis and one with congenital hepatic fibrosis) in whom cd was diagnosed following serological screening and gluten withdrawal led to improvement of hepatic function, eliminating the need for liver transplantation. |
PubMedID- 26125137 | Low cross-neutralization of hepatitis c correlates with liver disease in immunocompromized patients. |
PubMedID- 22087124 | Rosuvastatin reduces nonalcoholic fatty liver disease in patients with chronic hepatitis c treated with alpha-interferon and ribavirin: rosuvastatin reduces nafld in hcv patients. |
PubMedID- 21128862 | liver disease in patients with chronic hepatitis c virus (hcv) infection has an accelerated course in the presence of human immunodeficiency virus (hiv) coinfection. |
PubMedID- 22797645 | Effect of silymarin (milk thistle) on liver disease in patients with chronic hepatitis c unsuccessfully treated with interferon therapy: a randomized controlled trial. |
PubMedID- 19800334 | Background & aims: human immunodeficiency virus (hiv) infection accelerates liver disease progression in patients with hepatitis c virus (hcv) and could shorten survival of those awaiting liver transplants. |
PubMedID- 21911884 | Conclusion: based on our data, microsatellite variations in the hmox1 and ugt1a1 genes are not likely to protect from progression of liver disease in patients with chronic hepatitis c. |
PubMedID- 23633957 | These observations support a model of hepatic inflammation induced by phagocytic uptake of hcv by resident macrophages/kupffer cells to trigger il-1β and drive expression of proinflammatory cytokines, with il-1β expression associating with liver disease in patients with chronic hepatitis c infection (figure. |
PubMedID- 23061403 | In high income settings, chronic liver disease – associated with hepatitis c and b virus, long term drug-induced toxicity, alcohol related and non-alcoholic fatty liver disease – has become a leading cause of chronic morbidity and mortality in people living with hiv [14]. |
PubMedID- 23497336 | Eltrombopag, an oral, nonpeptide, thrombopoietin receptor agonist, increases platelet counts in adult patients with chronic immune thrombocytopenia (itp) [15-19] and chronic liver disease due to hepatitis c virus infection [20,21]. |
PubMedID- 25663852 | In the majority of cases, hcc originates from chronic liver diseases, mainly with progression from hepatitis b virus (hbv) and hepatitis c virus (hcv) to cirrhosis in asian populations. |
PubMedID- 20334631 | Site-specific k18 hyperphosphorylation was shown to strongly correlate with the progression of liver diseases in patients with chronic noncirrhotic hepatitis c virus (hcv) [17]. |
PubMedID- 23827008 | In many countries, the burden of chronic liver disease due to hepatitis b and c is increasing due to ageing of unvaccinated populations and migration, and a probable increase in drug injecting. |
PubMedID- 21294867 | The high proportion of patients with chronic liver disease associated with hepatitis c virus coinfection might have contributed to lessen the differences between treatment groups. |
PubMedID- 21191876 | [low response rate to a vaccination against hepatitis b in patients with end-stage liver disease]. |
PubMedID- 23722669 | Patients with hcv infection at presentation were included, but patients with complications such as underlying lymphoproliferative disorders, autoimmune diseases like lupus nephritis, infection, and liver disease due to hepatitis b virus or alcohol abuse were excluded. |
PubMedID- 23763386 | Aim: in chronic liver disease associated with hepatitis c virus (hcv), a low platelet count is a major obstacle in carrying out interferon (ifn) treatment. |
PubMedID- 25578311 | Platelets are key elements in the pathogenesis of acute and chronic liver disease associated with hepatitis b virus (hbv) infection by promoting the accumulation of virus-specific cd8(+) t cells and nonspecific inflammatory cells into the liver parenchyma. |
PubMedID- 22141390 | Entecavir: a review of its use in the treatment of chronic hepatitis b in patients with decompensated liver disease. |
PubMedID- 21057160 | Twenty-one patients (62%) had liver disease associated with hepatitis c virus (hcv) and 5 patients with hepatitis b virus (62%). |
PubMedID- 26357604 | Especially noticeable is the rapid decline by 47% from 1999 to 2006 of incidence rate of waiting list registration for end stage liver disease due to hepatitis b compared to that due to hepatitis c or non-viral liver disease.46 the temporal correlation of the trend and the availability of anti-hbv nucleos(t)ides, starting with use of lam in 1998, suggests that broad application of these medications, in part, contributed to the decreased incidence of decompensated chb disease. |
PubMedID- 21055694 | Morphologic aspects of liver disease associated with hepatitis b and c viruses, autoimmune hepatitis, and hiv infection were addressed, as was the prevalent problem of nonalcoholic fatty liver disease. |
PubMedID- 23626552 | In older patients, common predisposing conditions include cirrhosis in general, and in particular chronic liver disease associated with persistent hepatitis b and c infection. |
PubMedID- 20424599 | For hb, achieving safe, effective gene transfer in skeletal muscle would afford a therapeutic alternative to those patients with advanced liver disease due to hepatitis c contracted from plasma-derived coagulation concentrates. |
PubMedID- 20154579 | Introduction: since the advent of haart, liver-related mortality has become the leading cause of non-aids deaths in hiv-infected patients in western countries, complications of end-stage liver disease due to chronic hepatitis b, chronic hepatitis c or both being mainly responsible. |
PubMedID- 21331379 | Tlr-mediated signals result in liver disease associated with hepatitis b, hepatitis c, alcoholicnonalcoholic steatohepatitis, and hepatic fibrosis [19]. |
PubMedID- 20388084 | Most cases of hcc develop on a pre-existing chronic liver disease, usually due to hepatitis c virus (hcv), hepatitis b virus (hbv), or alcohol. |
PubMedID- 25131040 | The population had an average age of 57.5 years, predominantly formed by men (82.5%), with an average imc of 26.7, meld of 13, with viral hepatitis as main cause of liver disease. |
PubMedID- 21167429 | Severe forms of hepatitis are associated with underlying chronic liver disease such alcoholic disease. |
PubMedID- 22084743 | A 66-year-old man with chronic liver disease due to hepatitis b developed hepatocellular carcinoma for which a right partial hepatectomy was performed. |
PubMedID- 21743223 | She was suffering from end-stage liver disease due to hepatitis c virus (hcv) infection and renal disease due to diabetic nephropathy. |
PubMedID- 24695489 | End stage liver disease associated with hepatitis c virus infection constitutes one of the principal indications for liver transplant. |
PubMedID- 19330428 | Objective: the aim of this study was to establish standardization of modes of pt reporting by the interchangeability analysis of prothrombin time in patients with advanced liver disease associated with viral hepatitis measured with different thromboplastin reagents by the use of various methods of expression, i.e. |
PubMedID- 21031537 | Liver transplantation is currently the only definitive modality for the treatment of end-stage liver disease due to chronic hepatitis c. |
PubMedID- 22856889 | The misconception that severe liver disease due to hepatitis b would show symptoms may contribute to unwillingness of patients to take time to attend regular medical follow up[21], and this would cause deterioration of the disease condition if treatment is delayed. |
PubMedID- 22172892 | A 43-year-old man with end-stage liver disease due to hepatitis c and b virus infections and alcoholic cirrhosis received a liver transplantation under immunosuppressive treatment with tacrolimus and mycophenolate mofetil. |
PubMedID- 26294919 | Initial findings revealed that human bm-mscs were able to improve liver function in hepatitis b patients with end-stage liver disease [45]. |
PubMedID- 24693307 | Non-invasive histologic markers of liver disease in patients with chronic hepatitis b. |
PubMedID- 24768454 | The leading causes of chronic liver disease associated with hcc are hepatitis b and c viruses throughout the world, and alcohol and nash in france. |
PubMedID- 25266850 | Additionally, test and treat is recommended for selected groups of hiv-positive individuals, namely, (a) people with tuberculosis in 58 countries, (b) pregnant women in 42 countries, (c) people with liver disease due to hepatitis b co-infection in 52 countries, (d) serodiscordant couples in 35 countries and (e) children below 5 years in nine countries. |
PubMedID- 21040191 | Two of these 47 infants had liver disease; one was diagnosed with neonatal hepatitis syndrome, and the other was diagnosed with ba. |
PubMedID- 24651854 | Importantly, similar m2-like macrophage accumulation was confirmed in chronic hepatitis b patients with liver diseases. |
PubMedID- 25596623 | Additionally, risk factors such as heavy alcohol use or co-infection with hepatitis b may lead to progression of liver disease even in the presence of svr. |
PubMedID- 20386865 | The mechanisms by which alcohol consumption accelerates liver disease in patients with chronic hepatitis c virus (hcv) are not well understood. |
PubMedID- 24152445 | After stratification of our cohort, the association between the srebp1c variant and liver stiffness was replicated in the sub-cohort of patients with viral hepatitis, but not in patients with non-viral liver disease. |
PubMedID- 19902246 | Antiviral therapy of chronic hepatitis c in patients with advanced liver disease and after liver transplantation. |
PubMedID- 23801844 | Aim: to evaluate psychometrics of the chinese (mainland) chronic liver disease questionnaire (cldq) in patients with chronic hepatitis b (chb). |
PubMedID- 22434987 | Background: since the introduction of highly active anti-retroviral therapy and the dramatic improvement in the prognosis of individuals with human immunodeficiency virus, liver disease due to chronic viral hepatitis has become as important cause of morbidity and mortality in co-infected individuals. |
PubMedID- 22542039 | liver disease due to chronic hepatitis c is now a leading cause of mortality among hiv-infected patients in the developed world. |
PubMedID- 21343496 | Objective: the purpose of our study was to compare the utility of mr elastography (mre) and diffusion-weighted imaging (dwi) in characterizing fibrosis and chronic hepatitis in patients with chronic liver diseases. |